Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.
暂无分享,去创建一个
J. Cuzick | M. Arbyn | A. Szarewski | N. Wentzensen | J. Belinson | J. Gage | Michelle J. Khan | F. Verdoodt | Lan Xu
[1] J. Srisomboon,et al. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand , 2016, Journal of medical virology.
[2] M. Schiffman,et al. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. , 2015, Journal of the National Cancer Institute.
[3] Y. Qiao,et al. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China , 2015, Acta Cytologica.
[4] H. Kuramoto,et al. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions , 2015, Reproductive Sciences.
[5] M. Noguchi,et al. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study , 2015, International Journal of Clinical Oncology.
[6] M. Leeflang,et al. Cochrane diagnostic test accuracy reviews , 2013, Systematic Reviews.
[7] Â. Pista,et al. Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia , 2013, Journal of medical virology.
[8] C. Wheeler,et al. Risk of Precancer Determined by HPV Genotype Combinations in Women with Minor Cytologic Abnormalities , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[9] M. Leeflang,et al. Empirical Evidence of the Importance of Comparative Studies of Diagnostic Test Accuracy , 2013, Annals of Internal Medicine.
[10] M. Schiffman,et al. Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines , 2013, Journal of lower genital tract disease.
[11] Marc Arbyn,et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. , 2013, The Cochrane database of systematic reviews.
[12] J. Cuzick,et al. Human papillomavirus testing for triage of women with low‐grade squamous intraepithelial lesions , 2013, International journal of cancer.
[13] Julian Peto,et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. , 2012, Vaccine.
[14] A. Spathis,et al. mRNA and DNA Detection of Human Papillomaviruses in Women of All Ages Attending Two Colposcopy Clinics , 2012, PloS one.
[15] K. Seow,et al. Human papillomavirus genotyping as a predictor of high‐grade cervical dysplasia in women with mildly cytologic abnormalities: A two‐year follow‐up report , 2012, Diagnostic cytopathology.
[16] E. Pescarmona,et al. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy. , 2012, Gynecologic oncology.
[17] Roy Zhang,et al. Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population , 2012, Clinical Cancer Research.
[18] M. Schiffman,et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012 .
[19] J. Cuzick,et al. Comparison of Seven Tests for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study , 2012, Journal of Clinical Microbiology.
[20] D. Provencher,et al. Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance with cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of High-Grade Lesions of the Uterine Cervix , 2012, Journal of Clinical Microbiology.
[21] O. G. Wong,et al. Efficacy of Abbott RealTime High Risk HPV test in evaluation of atypical squamous cells of undetermined significance from an Asian screening population. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[22] Y. Liu,et al. A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study. , 2011, American journal of clinical pathology.
[23] T. Wright,et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. , 2011, American journal of clinical pathology.
[24] J. Bogers,et al. BD-ProExC as Adjunct Molecular Marker for Improved Detection of CIN2+ after HPV Primary Screening , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[25] A. Agostini,et al. Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[26] M. Einstein,et al. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology. , 2010, Gynecologic oncology.
[27] N. Segnan,et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] Penny Whiting,et al. Metandi: Meta-analysis of Diagnostic Accuracy Using Hierarchical Logistic Regression , 2009 .
[29] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PLoS medicine.
[30] K. Abravaya,et al. Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[31] S. Bose,et al. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance , 2009, Cancer.
[32] J. Dillner,et al. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate , 2009, Journal of cellular and molecular medicine.
[33] J. Cuzick,et al. Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears , 2008, Cancer Epidemiology Biomarkers & Prevention.
[34] A. Hjerpe,et al. Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities , 2008, British Journal of Cancer.
[35] K. Syrjänen,et al. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear , 2008, International journal of STD & AIDS.
[36] N. Sneige,et al. Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results , 2008, Modern Pathology.
[37] Gordon H Guyatt,et al. GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.
[38] Roger M Harbord,et al. A unification of models for meta-analysis of diagnostic accuracy studies. , 2007, Biostatistics.
[39] J. Dillner,et al. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. , 2006, Vaccine.
[40] M. Schiffman,et al. Determinants of human papillomavirus‐negative, low‐grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low‐grade squamous intraepithelial lesions triage study (ALTS) , 2005, Cancer.
[41] Jonathan J Deeks,et al. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. , 2005, Journal of clinical epidemiology.
[42] Joakim Dillner,et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. , 2004, Journal of the National Cancer Institute.
[43] Joan L. Walker. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. , 2003, American journal of obstetrics and gynecology.
[44] M. Sherman,et al. The 2001 Bethesda system: Terminology for reporting results of cervical cytology , 2002 .
[45] Mark Sherman,et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.
[46] A. Miller,et al. Natural history of dysplasia of the uterine cervix. , 1999, Journal of the National Cancer Institute.
[47] D. Evans,et al. Terminology in gynaecological cytopathology: report of the Working Party of The British Society for Clinical Cytology , 1986, Journal of clinical pathology.
[48] 小島原典子,et al. 診断精度研究のバイアスリスク評価ツールQUADAS-2:a Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies 2 の活用 , 2014 .
[49] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.
[50] Gerta Rucker,et al. Bmc Medical Research Methodology Open Access the Relationship between Quality of Research and Citation Frequency , 2006 .